SENSEX 75394.65 (-1.18)
Nifty 50 22830.6 (-1.05)
Nifty Bank 48810.95 (-1.20)
Nifty IT 41940.65 (-0.07)
Nifty Midcap 100 49492.15 (-2.74)
Nifty Next 50 59294.1 (-2.52)
Nifty Pharma 20976.75 (-1.28)
Nifty Smallcap 100 15545.7 (-3.29)
NIKKEI 225 38870.5 (0.18)
HANG SENG 21626.8 (1.56)
S&P 6099.5 (-0.08)
BSE Code : 524816 | NSE Symbol : NATCOPHARM | ISIN : INE987B01026 | Industry : Pharmaceuticals |
Hot Pursuit 10-Feb-2025 (10:39) NATCO Pharma gets final approval for its ANDA for Bosentan tablets
Corporate News 10-Feb-2025 (09:16) Natco Pharma receives USFDA approval for Bosentan tablets for oral suspension, 32mg
Hot Pursuit 06-Feb-2025 (13:06) Natco Pharma Ltd soars 3.15%, up for third straight session
Corporate News 31-Jan-2025 (10:24) Natco Pharma to hold board meeting
Hot Pursuit 30-Jan-2025 (12:57) NATCO Pharma gets approval for its ANDA for Everolimus tablets
Natco Pharma 13-Nov-2024
Natco Pharma 13-Aug-2024
Natco Pharma 28-May-2024
Total Foreign
Total Institutions
Total Govt Holding
Total Non Promoter Corporate Holding
Total Promoters
Total Public & others